ipratropium
Table of Contents
ipratropium
introduction
- a quaternary ammonium anticholinergic agent which is minimally absorbed (<1% of dose) when inhaled and thus has localised action to the respiratory system
- use is mainly confined to asthma and chronic obstructive pulmonary disease (COPD)
- paediatric doses via inhaler should ideally be delivered using a spacer.
- muscarinic M3 receptor action half life 3hrs ⇒ duration action 4-6hrs, max. response at 1.5-2hrs ⇒ qid dosing
dose
moderate-severe paediatric asthma
- < 6 years old: (Atrovent 20mcg/puff) 4 puffs then 2 puffs q6h
- > 6 years old: (Atrovent 20mcg/puff) 8 puffs1) then 4 puffs q6h
severe-critical paediatric asthma
- <20kg 250microg q20 mins x 3 via nebuliser then 2 puffs (40 microg) q6h
- >20kg 500microg q20 mins x 3 via nebuliser then 4 puffs (80 microg) q6h2)
ipratropium.txt · Last modified: 2009/03/10 07:11 by 127.0.0.1